Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Exchange Select Nicotine
Generic Name
Nicotine Polacrilex
Active Ingredient
NicotineCategory
Cholinergic Nicotinic Agonist [EPC]
Variants
4
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Exchange Select Nicotine, you must consult a qualified healthcare professional.
| 2 mg/1 | LOZENGE | ORAL | 55301-734 |
Detailed information about Exchange Select Nicotine
Nicotine is a cholinergic nicotinic agonist used primarily in nicotine replacement therapy (NRT) to facilitate smoking cessation by reducing withdrawal symptoms and cravings.
Dosage for nicotine replacement therapy (NRT) is highly individualized based on the patient's prior level of tobacco consumption. Healthcare providers typically use the 'Time to First Cigarette' (TTFC) or the number of cigarettes smoked per day to determine the starting dose.
Nicotine replacement products are generally not approved for use in patients under 18 years of age. The safety and efficacy of NRT in the pediatric population have not been established. Adolescents seeking smoking cessation assistance should consult a pediatrician, as behavioral interventions are preferred over pharmacological therapy in this age group.
Nicotine and its metabolites (cotinine) are cleared by the kidneys. In patients with severe renal impairment (CrCl < 30 mL/min), clearance may be reduced by up to 50%. While specific dose adjustment protocols are not standardized, healthcare providers often recommend using the lowest effective dose and monitoring closely for signs of nicotine toxicity (e.g., nausea, dizziness).
Since the liver (specifically CYP2A6) is the primary site of metabolism, patients with severe hepatic impairment (Child-Pugh Class C) may experience increased plasma levels of nicotine. Caution is advised, and dose reduction may be necessary to prevent adverse effects.
Elderly patients are more likely to have underlying cardiovascular conditions. While no specific age-based dose adjustment is required, healthcare providers typically monitor heart rate and blood pressure more frequently in this population during the initiation of NRT.
Proper administration is critical for the efficacy and safety of nicotine products:
If you miss a dose of NRT, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not 'double up' on doses or wear two patches at once, as this significantly increases the risk of overdose.
Signs of nicotine overdose (nicotine toxicity) include severe nausea, vomiting, diarrhea, dizziness, cold sweats, blurred vision, mental confusion, and tremors. In severe cases, hypotension, respiratory failure, and seizures may occur.
Emergency Measures: If an overdose is suspected, especially if a child has ingested nicotine or applied multiple patches, contact a Poison Control Center (1-800-222-1222) or seek emergency medical attention immediately. Remove any patches from the skin and wash the area with water (do not use soap, as it can increase absorption).
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or combine different types of NRT without medical guidance.
Most side effects of nicotine replacement therapy (NRT) are related to the delivery method rather than the systemic effects of nicotine itself. Common reactions include:
Nicotine is a potent pharmacological agent with significant effects on the cardiovascular and central nervous systems. It should only be used as part of a comprehensive smoking cessation program that includes behavioral support. Patients must be aware that using nicotine products while continuing to smoke cigarettes, use snuff, or use other tobacco products can lead to toxic levels of nicotine in the bloodstream.
No FDA black box warnings for Nicotine. However, users should strictly adhere to the 'Keep Out of Reach of Children' warning, as the amount of nicotine in a single unused or used patch can cause serious illness or death in a small child or pet.
There are no absolute drug-drug contraindications where nicotine cannot be used; however, it should never be combined with other nicotine-containing products (like cigarettes or electronic nicotine delivery systems) due to the risk of Nicotine Toxicity. The clinical consequence is a dangerous surge in blood pressure and heart rate, potentially leading to cardiac events.
Conditions where Nicotine must NEVER be used include:
FDA Pregnancy Category D. Nicotine readily crosses the placenta and is found in fetal tissues and amniotic fluid. Clinical data and animal studies indicate that nicotine exposure during pregnancy can lead to fetal growth restriction, decreased birth weight, and potential long-term neurodevelopmental issues. However, tobacco smoke contains thousands of other toxins (like carbon monoxide) that are even more harmful.
Clinical Recommendation: Pregnant women should first attempt to quit smoking using non-pharmacological methods (counseling, behavioral support). If these fail, a healthcare provider may prescribe NRT if the benefit of quitting smoking outweighs the risk of nicotine exposure. Intermittent delivery systems (gum, lozenges) are generally preferred over patches to minimize total daily nicotine exposure.
Nicotine is excreted into breast milk in amounts that can be significant. The milk-to-plasma ratio averages around 2.9. Infants exposed to nicotine through breast milk may experience tachycardia, restlessness, or gastrointestinal upset. To minimize exposure, breastfeeding mothers should use NRT immediately after nursing and allow as much time as possible before the next feeding. Despite these risks, the American Academy of Pediatrics generally considers the benefits of breastfeeding to outweigh the risks of NRT, provided the mother is successfully abstaining from tobacco smoke.
Nicotine is a potent agonist at nicotinic acetylcholine receptors (nAChRs). These are pentameric ionotropic receptors. In the brain, nicotine primarily binds to the α4β2 receptor subtype. This binding triggers the opening of the ion channel, allowing an influx of sodium (Na+) and calcium (Ca2+), which results in neuronal depolarization. This process stimulates the release of several neurotransmitters, including dopamine, norepinephrine, acetylcholine, serotonin, GABA, and endorphins. The release of dopamine in the mesolimbic reward pathway (from the ventral tegmental area to the nucleus accumbens) is the fundamental mechanism for its addictive properties and its ability to relieve withdrawal-related dysphoria.
Nicotine produces a dose-dependent increase in heart rate and blood pressure. At low doses, it primarily stimulates the autonomic ganglia. At very high doses (toxic levels), it can cause a biphasic response: initial stimulation followed by a persistent blockade of transmission (depolarizing block), which can lead to respiratory muscle paralysis. Tolerance develops rapidly to many of the effects of nicotine, particularly the 'nausea' and 'dizziness' associated with initial use, though the cardiovascular effects tend to persist.
Common questions about Exchange Select Nicotine
Nicotine is primarily used in Nicotine Replacement Therapy (NRT) to help people stop smoking or using tobacco products. It works by providing a controlled, low dose of nicotine to the body, which helps reduce the intense cravings and physical withdrawal symptoms that occur when someone quits. These symptoms often include irritability, anxiety, difficulty concentrating, and increased appetite. By managing these symptoms, nicotine products make it easier for a person to focus on the behavioral changes needed for long-term abstinence. It is available in several forms, including patches, gum, lozenges, and inhalers. It is also used in clinical settings for allergen testing and research purposes.
The most common side effects of nicotine replacement therapy are usually related to the way the product is administered. For those using the patch, skin redness or itching at the application site is very frequent. Users of nicotine gum or lozenges often report mouth irritation, a sore throat, or hiccups. Sleep-related issues, such as vivid dreams or difficulty falling asleep, are also common, especially if the patch is worn overnight. Some people may also experience mild nausea or headaches as their body adjusts to the medication. Most of these side effects are temporary and can be managed by adjusting the dose or switching to a different form of NRT.
While there is no direct dangerous interaction between alcohol and nicotine, healthcare providers often recommend limiting alcohol use during a quit attempt. Alcohol is a very common 'trigger' that can increase the urge to smoke, potentially leading to a relapse. Furthermore, alcohol can impair judgment, making it harder to stick to your smoking cessation plan. From a physical standpoint, alcohol does not change how nicotine works in your body, but it can worsen the dehydration or headaches some people feel when they stop smoking. For the best chance of success, it is often helpful to avoid alcohol-heavy environments in the first few weeks of therapy.
Nicotine is classified as FDA Pregnancy Category D, meaning there is evidence of potential risk to the fetus. Exposure to nicotine during pregnancy can contribute to low birth weight, premature birth, and issues with the baby's lung or brain development. However, smoking cigarettes is considered even more dangerous because it exposes the baby to carbon monoxide and thousands of other toxic chemicals. Doctors generally recommend that pregnant women try to quit smoking without using medications first. If that is not possible, a healthcare provider may decide that using a nicotine product is a safer alternative than continued smoking. You must discuss the risks and benefits thoroughly with your obstetrician before using any nicotine product while pregnant.
The time it takes for nicotine to work depends entirely on the form you are using. Nicotine nasal spray is the fastest-acting therapeutic form, reaching peak levels in the blood within 5 to 10 minutes. Nicotine gum and lozenges take slightly longer, usually about 20 to 30 minutes, because the nicotine must be absorbed through the lining of the mouth. The transdermal patch is the slowest, taking several hours to reach a steady level in the bloodstream, but it provides a consistent dose for 16 to 24 hours. Because the patch is slow-acting, it is used for 'background' craving control, while gum or lozenges are often used for 'breakthrough' cravings. Your doctor can help you choose the best timing for your needs.
While you can stop taking nicotine replacement products suddenly, it is generally not recommended. Most NRT programs are designed as a 'step-down' process where you gradually reduce the dose over 8 to 12 weeks. Stopping abruptly, especially if you are on a high-dose patch, can cause a return of withdrawal symptoms like extreme irritability, cravings, and anxiety, which increases the risk of returning to smoking. Tapering the dose allows your brain's receptors to slowly adjust to lower levels of nicotine, making the final transition to being nicotine-free much smoother. If you feel you are ready to stop sooner than planned, you should still consult with your healthcare provider to ensure you have a support plan in place.
If you miss a dose of nicotine replacement therapy, such as forgetting to apply a patch or missing a scheduled piece of gum, you should take it as soon as you realize it. However, if it is almost time for your next scheduled dose, it is better to skip the missed one and continue with your regular routine. You should never apply two patches at once or use double the amount of gum to make up for a missed dose, as this can lead to nicotine overdose. Symptoms of taking too much nicotine include nausea, dizziness, and a rapid heartbeat. Consistency is key to keeping withdrawal symptoms at bay, so try to keep your NRT products in a visible place to help you remember.
Nicotine itself is a mild appetite suppressant and slightly increases the body's metabolic rate, so it does not typically cause weight gain. In fact, many people gain weight when they *stop* using nicotine because their metabolism slows down and their appetite increases. Smoking cessation often leads to an average weight gain of 5 to 10 pounds as the body adjusts and people sometimes turn to food as a replacement for the hand-to-mouth habit of smoking. Using nicotine replacement therapy can actually help delay this weight gain during the quitting process. To manage weight changes, healthcare providers recommend focusing on physical activity and healthy snacking while you are using NRT to quit smoking.
Nicotine can be taken with many other medications, but some important adjustments may be needed. When you stop smoking tobacco, your body's ability to process certain drugs changes because the chemicals in smoke (not the nicotine) affect liver enzymes. For example, the doses of medications like theophylline (for asthma), insulin, or certain antipsychotics like clozapine may need to be adjusted by your doctor once you quit smoking. Additionally, nicotine can interfere with the way some blood pressure medications work because it naturally raises heart rate and blood pressure. Always provide your healthcare provider with a complete list of all prescriptions, over-the-counter drugs, and herbal supplements you are taking before starting nicotine therapy.
Yes, nicotine replacement products are widely available in generic forms. Generic versions of the transdermal patch, gum, and lozenges are sold over-the-counter at most pharmacies and grocery stores. These generic products contain the same active ingredient and meet the same FDA standards for quality and effectiveness as the brand-name versions (like Nicoderm CQ or Nicorette). Choosing a generic version can be a significantly more cost-effective way to manage your smoking cessation journey. Some prescription-only forms, like the nicotine nasal spray or inhaler, may also have generic alternatives available depending on your region. Check with your pharmacist to see which generic options are most suitable for you.
Other drugs with the same active ingredient (Nicotine)
While NRT is generally safe, certain symptoms require immediate medical intervention. These may indicate an underlying cardiovascular event or a severe systemic reaction.
> Warning: Stop taking Nicotine and call your doctor immediately if you experience any of these:
Nicotine itself is a sympathomimetic agent. Long-term use of NRT (beyond the recommended 3–6 months) may lead to persistent elevations in heart rate and blood pressure, potentially increasing the workload on the cardiovascular system. There is also a risk of developing a long-term dependency on the NRT product itself, although this is considered significantly less harmful than returning to tobacco smoking. Chronic use of nicotine gum has occasionally been linked to dental issues or jaw pain (TMJ syndrome).
There are currently no FDA black box warnings for nicotine replacement therapy products. However, the FDA requires prominent warnings on packaging regarding the risks of continued smoking while using NRT and the importance of keeping these products away from children and pets due to the risk of fatal poisoning.
Report any unusual symptoms or persistent side effects to your healthcare provider. Monitoring of blood pressure and heart rate is recommended for patients with pre-existing cardiovascular conditions.
Patients using nicotine for smoking cessation should undergo the following monitoring:
Nicotine generally does not impair the ability to drive or operate machinery. However, some users may experience dizziness or lightheadedness during the initial days of therapy. Patients should assess their individual reaction to the medication before engaging in potentially dangerous activities.
There is no direct pharmacological contraindication between alcohol and nicotine. However, alcohol is a frequent 'trigger' for smoking relapse. Patients are often advised to limit alcohol consumption during the initial weeks of a quit attempt to increase the likelihood of success.
Nicotine therapy should be tapered according to the manufacturer's 'step-down' schedule. Abrupt discontinuation of high-dose NRT can result in withdrawal symptoms, including intense cravings, irritability, anxiety, and increased appetite. If a patient is unable to successfully taper off NRT within the recommended timeframe, they should consult their healthcare provider for an extended cessation strategy.
> Important: Discuss all your medical conditions, especially heart problems or recent surgeries, with your healthcare provider before starting Nicotine.
It is vital to distinguish between interactions with nicotine and interactions with tobacco smoke. Tobacco smoke contains polycyclic aromatic hydrocarbons that induce the CYP1A2 enzyme. When a patient stops smoking (even while using NRT), CYP1A2 activity decreases, which can significantly increase the blood levels of the following drugs:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially if you are currently taking medications for asthma, heart disease, or mental health conditions.
Conditions requiring a careful risk-benefit analysis by a healthcare provider:
Patients who have experienced contact dermatitis with other adhesive bandages or transdermal systems (such as nitroglycerin or scopolamine patches) may have an increased risk of skin reactions to the nicotine patch. Similarly, individuals with sensitivities to certain flavoring agents (like cinnamon or mint) should choose unflavored or alternative-flavored nicotine gum or lozenges to avoid oral mucosal irritation.
> Important: Your healthcare provider will evaluate your complete medical history, including any recent heart procedures or chronic gastrointestinal issues, before recommending Nicotine.
Nicotine products are not approved for use in children or adolescents under 18. There is significant concern regarding the impact of nicotine on the developing adolescent brain, particularly regarding the 'priming' of reward pathways and the risk of lifelong addiction. Clinical guidelines emphasize behavioral interventions as the first-line treatment for adolescents who smoke.
In patients over 65, the primary concern is the higher prevalence of underlying cardiovascular disease. While nicotine clearance may be slightly reduced due to age-related declines in hepatic or renal function, no specific dose adjustments are typically required. However, elderly patients should be monitored more closely for hypertension and arrhythmias. The risk of skin thinning in the elderly may also increase the likelihood of irritation from transdermal patches.
In patients with severe renal impairment (CrCl < 30 mL/min), the clearance of nicotine and its metabolite cotinine is significantly reduced. This can lead to accumulation and an increased risk of side effects. Healthcare providers may recommend starting at the lowest possible dose (e.g., 7mg patch or 2mg gum) and extending the interval between doses.
Since nicotine is extensively metabolized by the liver, moderate to severe hepatic impairment can increase plasma concentrations. Patients with Child-Pugh Class B or C impairment should be monitored for signs of nicotine toxicity. Dose reductions are often necessary to ensure safety while still managing withdrawal symptoms.
> Important: Special populations require individualized medical assessment. Never start NRT during pregnancy or for a minor without direct medical supervision.
| Parameter | Value |
|---|---|
| Bioavailability | 5% (swallowed), 50-80% (buccal/nasal), 70-90% (transdermal) |
| Protein Binding | < 5% |
| Half-life | ~2 hours (Nicotine), ~16 hours (Cotinine) |
| Tmax | 1-2 mins (smoke), 5-10 mins (nasal), 30 mins (gum), 2-6 hours (patch) |
| Metabolism | Hepatic (90%), primarily via CYP2A6 to Cotinine |
| Excretion | Renal (10-20% unchanged) |
Nicotine is the prototypical member of the Cholinergic Nicotinic Agonist class. It is therapeutically grouped with other smoking cessation aids, such as varenicline (a partial nicotinic agonist) and cytisine. Unlike muscarinic agonists (like pilocarpine), nicotine acts specifically on the nicotinic receptors found at the neuromuscular junction, autonomic ganglia, and the CNS.